Vildagliptin Attenuates Huntington ’s Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model

In conclusion, Vilda purveyed significant anti-Huntington effect which may be mediated, at least in part, via activation of GLP-1/PI3K/Akt pathway in 3NP rat model.

http://link.springer.com/10.1007/s13311-019-00805-5

Source: Neurotherapeutics - November 13, 2019 Category: Neurology Source Type: research